ArthroCare Expands Accounting Inquiry To All Divisions Dating Back To 2000
This article was originally published in The Gray Sheet
Troubled surgical instrument maker ArthroCare will expand the scope of a previously planned restatement of financial results to encompass all three of its business units for the past eight years to account for improper recording of sales to certain entities
You may also be interested in...
Ex-ArthroCare Chiefs Convicted Of Orchestrating Fraud
The former top leaders of ArthroCare have been convicted for working in cahoots with distributors to overstate ArthroCare’s earnings. Both face significant prison time for their roles in the scam, according to the Department of Justice.
News In Brief
AdvaMed presents CEO survey to FDA. Former ArthoCare exec pleads guilty to securities fraud charges from DOJ. CMS lists teaching hospitals that qualify for inclusion in company’s physician payment sunshine disclosure requirements. More news.
ArthroCare CEO Resigns As Inquiry Into Accounting, Billing Practices Expands
Veteran health care exec and ArthroCare board member David Fitzgerald will step in as acting CEO of the embattled surgical instrument maker now that former chief exec Michael Baker has resigned in the shadow of an accounting scandal and government investigations